Recently, the National Cancer Institute published a comprehensive monograph on multiple primary cancers in Connecticut and Denmark [1] 
INTRODUCTION
A comprehensive monograph on the risk of developing multiple primary cancers has recently been prepared by the National Cancer Institute in conjunction with the Connecticut Tumor Registry and the Danish Cancer Registry [ 1] . The reader interested in more details on the historical review, subjects and methods, results, and discussion is referred to this volume. Our paper attempts to provide an overview of the major findings with emphasis on results of interest to the Connecticut community. This monograph is the source of material for the sections following.
SUMMARY OF MONOGRAPH FINDINGS All First Cancers Combined
Data from 253,536 Connecticut patients diagnosed with an invasive cancer during 1935 to 1982 who survived at least two months without developing a simultaneous primary were combined so that their collective risk of second primary cancer over time could be examined [2] . More than 1,100,000 person-years of follow-up were accumulated for an average of 4.5 years per person. Both the first and second cancers were microscopically confirmed 88 percent of the time. A new primary neoplasm developed in 16,727 (6.6 percent) patients, whereas 12,797 second cancers were expected on the basis of rates from the general Connecticut population. Thus, patients with one cancer had 1.31 , although almost twenty additional years of cancer diagnoses and follow-up were added to the Connecticut data base [3] . The risk of developing a second cancer was 14.7 per 1,000 persons per year, and the excess risk, i.e., after removing the expected incidence based on population rates, was 3.5 per 1,000 persons per year.
Connecticut residents with cancer remained at increased risk for a new malignant neoplasm throughout their lifetimes. Moreover, the risk increased from 1 Table 1 and are further discussed below, emphasizing the new findings from the current investigation.
Tobacco and Alcohol Table 2 presents recent findings from Connecticut suggesting the possible influence of cigarette smoking and/or alcohol consumption on the development of both first and second cancers [5] . Figure 2 depicts the high risk of developing a new cancer of the oral cavity following a primary cancer of the lung over time and further exemplifies the continuing influence of past or current exposures on cancer risk. Tobacco smoking is clearly one of the major causes of second cancers as it is for the first cancers [6] . Previous studies of second tumors among patients with lung cancer have found excess cancers of the oral cavity, larynx, bladder, cervix, and other tobacco-related sites [3, 7, 8, 9, 10, 11] . The combined effects of tobacco and alcohol account largely for the constellation of multiple cancers arising in the oral cavity, larynx, and esophagus. The risks of developing a second tobacco-or alcohol-related Table 3 presents recent findings from Connecticut confirming the significant associations previously reported for cancers of the colon, breast, uterine corpus, and ovary [12, 13, 14] . The bidirectional nature of these associations is remarkable. Figure 3 indicates the elevated risk of a second cancer of the female breast over time following an initial primary breast cancer. These high risks could be associated with hormonal, dietary, and/or genetic influences, as well as heightened medical surveillance. The constellation of multiple cancers of the breast, uterine corpus, ovary, and colon has long intrigued investigators [1 5,16,17,18,19,20] Because reproductive factors (e.g., nulliparity) and dietary habits (e.g., high fat intake) appear involved in these cancers, some think that nutritional and hormonal interactions may contribute to the development of multiple primaries of these sites [21, 22] . Genetic Predisposition Table 4 presents recent findings from Connecticut suggesting the possible influence of genetic predisposition on the development of some multicentric cancers and also on the high risk of osteosarcoma after retinoblastoma [2, 23] . Although it is unlikely that hereditary cancers contribute substantially to the overall incidence of second tumors among cancer patients, some complexes of tumors result from genetic factors. The association between bilateral retinoblastoma and osteosarcoma illustrates the influence of hereditary factors [24] . Genetic predisposition may also contribute to multicentric cancers arising in the colon and bilateral breast cancer, which are associated with a tendency to familial aggregation. (Table 5) are noteworthy since these sites can receive intense radiation exposures. Figure 4 indicates the high risk of bladder cancer possibly associated with radiotherapy for cervical cancer [ 14] , and Fig. 5 indicates the high risk of acute non-lymphocytic-leukemia (ANLL) that appears linked to chemotherapy for ovarian cancer [2, 27] . Clearly, in the absence of such Bladder after Cervix [28] . During the last twenty years, the number of cancer patients treated with radiation and chemotherapy has increased, and the study of therapy-related second cancers has become more important [28, 29] . Children treated with radiotherapy have been reported at high risk of second cancers [30, 31] , although the risk of subsequent leukemia does not seem significantly affected by radiation [32] . Cervical cancer patients exposed to high-dose radiotherapy are prone to develop cancers of the rectum and other sites within the pelvis that receive substantial radiation exposures [33] . In this group, a significantly low rate of breast cancer appears due, in large part, to a protective effect resulting from ovarian ablation. Radiotherapy increases the risk of leukemia following relatively low-dose total body irradiation for NHL [34] and of osteosarcomas following high-dose radiotherapy for Ewing's sarcoma [35] and retinoblastoma [24] . Soft tissue sarcomas also appear to be a rare consequence of high-dose radiotherapy for cancer [36] . Estrogen therapy and ovarian radiotherapy for breast cancer have both been related to an increased risk of endometrial cancer [37, 38] . Alkylating agents have been associated with extremely high risks of subsequent ANLL following treatment for ovarian cancer [27] , gastrointestinal cancers [39] , breast cancer [40] , multiple myeloma [41] , lung cancer [42] , Hodgkin's disease [43, 44] , NHL [34] , and childhood cancers [31] . Cyclophosphamide, an alkylating agent, has been associated with bladder cancer as well as chronic cystitis [45] . Immunologic Defects Table 7 presents recent data from Connecticut suggesting the role of immunosuppression in the development of second skin cancers [46] . Figure 6 indicates the high risk of stomach cancer after NHL due to radiation therapy or to immunosuppression. Stomach cancer is known to complicate certain states of immunodeficiency [47, 48] , and the immune defects which accompany lymphoma may be aggravated by radiation or chemotherapy [49] . Certain cancers are thought to be complicated by immunodeficiency states which appear to predispose to certain cancers. For example, skin cancers (melanoma and non-melanoma) have occurred excessively after chronic lymphocytic leukemia [50] . An increase of NHL following Hodgkin's disease has been linked to the immunosuppressive effects of combination chemotherapy and radiotherapy [51] . Various cancers, in particular NHL, have occurred excessively in organ transplant recipients treated with immunosuppressants [48] .
Obscure Mechanisms A number of associations between cancers have been reported without apparent explanation. For example, cancers of the breast and salivary gland have clustered in several [52, 53, 54] but not all studies [55, 56] , and leukemia has occurred excessively following cancer of the testis [3] , but the mechanisms are uncertain. Table 8 presents some tumor relationships from Connecticut for which no explanation appears obvious [2] . Leukemia, for example, has been found in excess following cancers of the prostate, testis, and lip. Due to the multiple comparisons made, chance cannot be easily ruled out; however, some of the associations might provide leads for new etiologic hypotheses. [4] . Risk factors common to multiple cancer have also varied over time, as illustrated by the increasing proportion of smokers among women in our population [57] . Intense medical surveillance and conditions peculiar to the evaluation of second cancers (e.g., misclassified metastases and autopsy diagnoses) may also affect the reported incidence of second cancers. Medical surveillance bias, for example, may have been responsible for the high rates of second cancers of the prostate, kidney, and thyroid frequently seen in Connecticut (Table 9) . Interestingly, only patients with prostate cancer were at significantly low risk for second cancer development; however, this might be an artifact of case-finding, since advanced age at initial diagnosis was generally associated with an underascertainment of second cancer. The frequency of autopsies also contributes to the number of second cancers. For example, 1,280 second prostate cancers were observed overall compared to 893 expected, but 316 of the 387 excess prostate cancers were identified Table 10 , the autopsy diagnoses were responsible in large part for the significance of the findings. The practice of radiation therapy has also changed as supervoltage machines have replaced orthovoltage units, and different dose distributions to organs receiving scatter radiation may alter the pattern of second cancer occurrence. New therapies such as chemotherapy have been introduced and affect the risk of some second cancers, most notably ANLL [28] . Some findings might be influenced by changing coding classifications of cancer and by misclassifications of therapy in registry records. Finally, in any analysis which involves a large number of comparisons, one can expect spurious associations to develop based on chance alone. The special advantages of this survey, however, are the exceptionally large number of subjects studied in a population-based cancer registry, the long follow-up available (almost fifty years), and the strict criteria used by a single registry to record second primary cancers. Thus, our survey of multiple primary cancers in Connecticut provides investigators with a special opportunity to estimate risks and clarify constellations of multiple cancer. A better understanding of multiple cancers should yield greater insights into the risk factors and basic mechanisms of carcinogenesis and provide a more sound basis for the management of cancer-prone individuals, including the development of protective measures.
